...ty; Stenting; Unstable angina pectoris 随着经皮冠状动脉腔内血管成形术(Percutaneous Transluminal Coronary Angioplasty, PTCA)与支架植入术在临床上的广泛使用，较高的再狭窄率一直是临床心脏病介入治疗密切关注的问题［1］。
基于10个网页-相关网页
...伤后冠状动脉再狭窄的实验研究 前言： 经皮冠状动脉腔内血管成形术(Percutaneous transluminal coronary angioplasty，PTCA)及支架置入术是当前治疗冠状动脉粥样硬化性心脏病最为有效的重要手段之一，但术后6个月内再狭窄的发生率高...
基于4个网页-相关网页
结论：分段血管腔内成形术和膝下动脉行pta后应用尿激酶对提高PTA的成功率和近期通畅率有帮助。
Conclusions: Segmental transluminal angioplasty and application of urokinase after below-knee artery PTA are helpful to the success of operation and short-term patency.
目的评价兔髂动脉内近距离治疗预防经皮经腔血管成形术（PTA）后再狭窄的可行性及作用。
Objective To evaluate the role of intra arterial brachytherapy to prevent the iliac artery restenosis in the rabbit following percutaneous transluminal angioplasty (PTA).
目的血管腔内支架成形术目前已被证明是治疗外周动脉硬化闭塞症（PAOD）的有效方法，然而术后出现的再狭窄影响了支架成形术的疗效。
Objective:It is proved that Percutaneous Transluminal Angioplasty and Stenting is a effective treatment of PAOD, but its benefits is seriosly limited by local thrombotic occlusion and restenosis.
应用推荐